X

NKCF News

Heart Condition Associated with KC

Forty years ago, the first article was published reporting that individuals with keratoconus (KC) appeared to have a higher-than-average incidence…

Walking in Sunshine

During early clinical trials for cornea crosslinking (CXL), ophthalmologist Dr. John Jarstand MD of Evergreen Eye Center in Washington met a…

Blepharitis: why eyelids get red & itchy

Regretfully, many individuals with keratoconus also suffer from other conditions affecting the health and comfort of their eyes. Dry eye…

May 2021 Update Newsletter

Click here to read the May 2021 NKCF Newsletter

What Happens After CXL? Results from an NKCF Update Survey

   In the February NKCF Update, we asked those who had corneal crosslinking (CXL) about their experience.  Seventeen people responded.  We thank…

TOP DOCS of 2021

TOP DOCS OF 2021 NKCF Update readers submitted stories about their doctor as part of our annual celebration honoring eye…

New Artificial Cornea in Clinical Trials

CorNeat Vision, a medical device company based in Israel is conducting a clinical trial to test the safety and efficacy…

Corneal Transplant Patients & COVID-19

FAQs about Crosslinking

NKCF has compiled a list of commonly asked questions regarding corneal crosslinking (CXL). Visit the Answering Your Questions about Crosslinking page…

Identifying a KC Gene

Scientists searching for a single, simple genetic answer responsible for keratoconus have been disappointed, but as our understanding of genetic…